Syfovre gets FDA approval for GA
Apellis’ Syfovre (pegcetacoplan injection) has become the first US Food and Drug Administration (FDA) -approved treatment for geographic atrophy (GA) secondary to age-related macular degeneration
1 min read
SR
Staff reporters
4295 articles
Pacific eye-health survey
The University of Auckland (UoA) is collaborating with Fred Hollows Foundation New Zealand to undertake a new and ambitious Pacific-focused research programme.
2 min read
A French-Californian classic
Partnering with elegant and understated French clothing brand, Officine Générale, Garrett Leight California Optical (GLCO) has created a limited-edition frame blending French and Californian style suited to optical and sun wear.
1 min read
RANZCO 2023: reconnecting vision
Planning is well underway for the 54th Royal Australian and New Zealand College of Ophthalmologist’s (RANZCO’s) annual scientific congress, ‘Reconnecting vision’, scheduled for 20-23 October at the Perth Convention and Exhibition Centre.
1 min read
Optic nerve-repair molecule?
Researchers in China have identified a small molecule which restores visual function following optic nerve damage.
1 min read
Smart CL offers 24h IOP monitoring
The US developers of a smart contact lens (CL) claim it will continuously monitor intraocular pressure (IOP) in glaucoma patients, even as they sleep.
1 min read
Cutting-edge design
Building on the release of its Wireframe campaign, the new Blackfin One optical collection follows in its tracks with an exclusive stylistic expression.
1 min read
Scraping the bottom in wait times
Australia and New Zealand have some of the longest healthcare waiting times in the OECD, second and fifth from the bottom, respectively, a new study has found.
2 min read
AMD’s obesity link
Canadian researchers investigating why only some genetically predisposed individuals develop age-related macular degeneration (AMD) have found obesity leads to persistent changes in immune-cell DNA, making the cells more susceptible to producing inflammatory molecules.
1 min read
Robotic radiotherapy deemed safe
Treating benign tumours with robotic fractionated radiotherapy near the optical pathway is safe and does not impact vision, despite minor changes in optic-nerve anatomy, according to the authors of a Polish study.
2 min read
European pilot project for Toku Eyes
Backed by Bayer Spain, Barcelona’s Right Care Foundation (RCF) is using Auckland’s Toku Eyes’ AI platform to train doctors in early detection of diseases through retinal imaging.
2 min read
Ramping up glaucoma awareness
Glaucoma New Zealand (GNZ) is running a comprehensive awareness campaign leading up to this year’s World Glaucoma Week (12-18 March) encouraging 40-year-olds to seek out their local optometrist and get an eye test.
2 min read